September 15, 2025

The Hidden Hazard: Fall-Risk Drugs

US fall-related deaths in older adults are rising, with prescription drugs a key contributor and safer alternatives urged.

KFF Health News

September 15, 2025

New Insights into Duodenal Neuroendocrine Tumor Profiles

Researchers identify expanded hormone and transcription factor profiles in duodenal neuroendocrine tumors.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 12, 2025

Cemiplimab Reduces Recurrence in High-Risk cSCC

First adjuvant immunotherapy trial shows 23% absolute reduction in recurrence for resected cutaneous squamous cell carcinoma.

Conexiant

September 11, 2025

Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1/KMT2A Alterations

A new combination of azacitidine, venetoclax, and revumenib demonstrated high rates of complete response and clinical activity in older adults with newly diagnosed acute myeloid leukemia and an NPM1 m...

The ASCO Post

September 10, 2025

Medical Societies Challenge Kennedy

"That you can no longer trust the recommendations out of the CDC is just devastating."

Conexiant

September 10, 2025

Study Ties Diet to Lung Cancer Risk

High consumption of ultra-processed foods was associated with increased risk of lung cancer, including both non-small cell and small cell subtypes.

Conexiant

September 09, 2025

Merger Cure? Rural Hospitals Try Networks

Mobile magnetic resonance imaging units and rural hospital networks support independent hospitals in improving access to diagnostic imaging and patient care in underserved areas.

KFF Health News

September 08, 2025

FDA Expands Indications for Von Willebrand Disease

FDA expands Vonvendi to adult routine prophylaxis (types 1 and 2) and pediatric on-demand/perioperative use.

Conexiant